151 related articles for article (PubMed ID: 378864)
1. The use of prostacyclin, PGI2, in the prevention of platelet aggregation during charcoal haemoperfusion.
Langley PG; Hughes RD; Ton HY; Silk DB; Williams R
Int J Artif Organs; 1979 Jul; 2(4):207-10. PubMed ID: 378864
[TBL] [Abstract][Full Text] [Related]
2. Prostacyclin to prevent platelet activation during charcoal haemoperfusion in fulminant hepatic failure.
Gimson AE; Langley PG; Hughes RD; Canalese J; Mellon PJ; Williams R; Woods HF; Weston MJ
Lancet; 1980 Jan; 1(8161):173-5. PubMed ID: 6101632
[TBL] [Abstract][Full Text] [Related]
3. Earlier charcoal haemoperfusion in fulminant hepatic failure.
Gimson AE; Braude S; Mellon PJ; Canalese J; Williams R
Lancet; 1982 Sep; 2(8300):681-3. PubMed ID: 6126626
[TBL] [Abstract][Full Text] [Related]
4. Prostacyclin eliminates the bioincompatibility of charcoal haemoperfusion.
Weston MJ; Woods HF; Bunting S; Moncada S; Vane JR
Proc Eur Dial Transplant Assoc; 1979; 16():225-31. PubMed ID: 398492
[TBL] [Abstract][Full Text] [Related]
5. In-vitro blood compatibility studies on a new polymer-coated charcoal for haemoperfusion.
Hughes RD; Langley PG; Williams R
Int J Artif Organs; 1980 Sep; 3(5):277-9. PubMed ID: 7461861
[TBL] [Abstract][Full Text] [Related]
6. The effect of prostaglandin E1 and adenosine on adverse platelet reactions during charcoal haemoperfusion.
Langley PG; Hughes RD; Ton HY; Silk DB; Williams R
Thromb Res; 1978 Sep; 13(3):351-60. PubMed ID: 741432
[No Abstract] [Full Text] [Related]
7. Platelet function during haemoperfusion in acute liver failure.
Hughes RD; Lane DA; Cella G; Kakkar VV; Langley PG; Williams R
Int J Artif Organs; 1980 Jan; 3(1):30-4. PubMed ID: 6444397
[TBL] [Abstract][Full Text] [Related]
8. Biocompatibility of coated and uncoated charcoal during haemoperfusion in healthy dogs.
Weston MJ; Hanid A; Rubin MH; Langley PG; Mellon PJ; Williams R
Eur J Clin Invest; 1977 Oct; 7(5):401-6. PubMed ID: 411670
[TBL] [Abstract][Full Text] [Related]
9. Clinical experience with the use of charcoal haemoperfusion: is prostacyclin required?
Kennedy HJ; Greaves M; Triger DR
Life Support Syst; 1985; 3(2):115-22. PubMed ID: 3894813
[TBL] [Abstract][Full Text] [Related]
10. Prostacyclin eliminates the thrombocytopenia associated with charcoal hemoperfusion and minimizes heparin and fibrinogen consumption.
Woods HF; Weston MJ; Bunting S; Moncada S; Vane J
Artif Organs; 1980 Aug; 4(3):176-9. PubMed ID: 6998437
[TBL] [Abstract][Full Text] [Related]
11. 9 beta-methylcarbacyclin, a stable prostacyclin analogue, in prevention of platelet losses during charcoal haemoperfusion.
Hughes RD; Langley PG; Guarner F; Williams R
J Pharm Pharmacol; 1986 Jan; 38(1):63-5. PubMed ID: 2869131
[TBL] [Abstract][Full Text] [Related]
12. Platelet function in fulminant hepatic failure and effect of charcoal haemoperfusion.
Weston MJ; Langley PG; Rubin MH; Hanid MA; Mellon P; Williams R
Gut; 1977 Nov; 18(11):897-902. PubMed ID: 590850
[TBL] [Abstract][Full Text] [Related]
13. Prostacyclin can replace heparin in haemodialysis in dogs.
Woods HF; Ash G; Weston MJ; Bunting S; Moncada S; Vane JR
Lancet; 1978 Nov; 2(8099):1075-7. PubMed ID: 82090
[TBL] [Abstract][Full Text] [Related]
14. Clinical experience with charcoal and resin hemoperfusion.
Hughes R; Williams R
Semin Liver Dis; 1986 May; 6(2):164-73. PubMed ID: 3018936
[No Abstract] [Full Text] [Related]
15. Platelet sensitivity to adenosine diphosphate and to prostacyclin in diabetic patients.
Onodera H; Hirata T; Sugawara H; Sugai K; Yoda B; Toyota T; Goto Y
Tohoku J Exp Med; 1982 Aug; 137(4):423-8. PubMed ID: 6750843
[TBL] [Abstract][Full Text] [Related]
16. Prostacyclin (PGI2) and the effect of phosphodiesterase inhibitors on platelet aggregation.
Jørgensen KA; Dyerberg J; Stoffersen E
Pharmacol Res Commun; 1979 Jul; 11(7):605-15. PubMed ID: 388470
[No Abstract] [Full Text] [Related]
17. [Platelet sensitivity to prostacyclin (PGI2) in patients with juvenile-onset diabetes mellitus (author's transl)].
Klein K; Sinzinger H; Schernthaner G; Silberbauer K; Prager R
Wien Klin Wochenschr; 1981 Jul; 93(14):460-2. PubMed ID: 7023074
[TBL] [Abstract][Full Text] [Related]
18. Effects of prostacyclin on platelet aggregation as studied with "filter-loop" technique in the flowing blood of the dog.
Imai S; Matsubara I
Artery; 1980; 8(1):63-72. PubMed ID: 7000043
[TBL] [Abstract][Full Text] [Related]
19. Prostacyclin (PGI2) inhibits the formation of platelet thrombi induced by adenosine diphosphate (ADP) in vivo [proceedings].
Higgs GA; Moncada S; Vane JR
Br J Pharmacol; 1977 Sep; 61(1):137P. PubMed ID: 334306
[No Abstract] [Full Text] [Related]
20. Effect of prostacyclin on platelet-activating factor induced rabbit and platelet aggregation.
Bussolino F; Camussi G
Prostaglandins; 1980 Nov; 20(5):781-91. PubMed ID: 6258196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
